Stock Analysis
Danaher CorporationDHR
P/E 40.21×· 5Y range 23.21–52.87×· 69th percentile of history
Sector: Healthcare · Industry: Diagnostics & Research
AnalystsStrong Buy32 analystsP/E 40.2× sits at the 69th percentile of its 5.086926762491444-year history.
Cash covers 16% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, fairly valued
Strengths
- Quality85
- Financial Health80
Risks
- Growth25
- Profitability50
Mixed picture — no clear quality or value edge.
Bull Case
- ✓Altman Z 3.5 — safe-zone balance sheet
- ✓Interest coverage 20.2× — debt well covered
What's happening with DHR
Profile
Strong earnings quality, financial health and moat; growth and valuation lag behind.
How is each axis scored?
- Valuation34/100 · Weak
- P/E vs own history (69th pct)5/25
- FCF yield (3.4%)12/25
- P/S (6.4x)12/25
- EV/EBIT (36.0x)5/25
- Growth25/100 · Weak
- Revenue CAGR (-4.4%)0/25
- Net income CAGR (-13.4%)0/25
- EPS CAGR 5Y (-12.8%)0/25
- Fwd implied growth (65.0%)25/25
- Profitability50/100 · Moderate
- ROIC (5.3%)5/25
- ROE (7.6%)5/25
- Net margin (15.9%)20/25
- Operating margin (20.4%)20/25
- Financial Health80/100 · Strong
- Altman Z (3.47)25/25
- Current ratio (1.65)18/25
- Interest coverage (20.2x)25/25
- Net cash / debt (D/A 25%)12/25
- Quality85/100 · Strong
- Piotroski F (5/9)15/25
- Beneish M (-2.37)20/25
- FCF conversion (137%)25/25
- Margin stability (σ 4.7%)25/25
- Moat75/100 · Strong
- ROIC >12% years (0/10 yrs)0/25
- Median gross margin (57.4%)25/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 13.3%)25/25
Risk Flags
- ⚠Revenue shrinking 4.4%/yr
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Show more
Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Headquarters: WASHINGTON, DC · Employees: 60,000 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
34DP/E (TTM)40.2xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 23.2x–52.9x · 69th pct
P/FCF29.5xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield3.4%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 2.4%–4.9% · 42nd pct
P/S (TTM)6.41xC
Grade C: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 4.6x–10.3x · 57th pct
EV/EBIT36.0xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 21.2x–55.5x · 68th pct
EV/Sales7.3xC
Grade C: ExpensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E24.4xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio3.06xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio4.21D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield0.60%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio24.1%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
50CROIC5.3%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE7.6%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA4.7%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin15.9%A
Grade A: HighNet Income / Revenue
Operating Margin20.4%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin58.5%A
Grade A: PremiumGross Profit / Revenue
FCF Margin21.8%A
Grade A: HighFCF / Revenue
True FCF Margin20.6%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
25ERevenue CAGR-4.4%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR-13.4%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)-12.8%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth65.0%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-4.4%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income7.4%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue1.2%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
80AAltman Z-Score3.47A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.65xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.15xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage20.2xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment4.3yC
Grade C: AverageYears to repay net debt via FCF
Net Debt/EBIT4.6xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity0.53xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.16xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
85APiotroski F-Score5/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.37A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion136.5%A
Grade A: StrongFCF / Net Income
Margin Stability4.7%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue4.7%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.30xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
RALES MITCHELL P Filed | RALES MITCHELL P | SellDisposition | -500000 | |
RALES STEVEN M Filed | RALES STEVEN M | SellDisposition | -500000 | |
Blair Rainer Filed | Blair Rainer | SellOpen market sale | -7755 | |
Blair Rainer Filed | Blair Rainer | SellOpen market sale | -39193 | |
Blair Rainer Filed | Blair Rainer | SellOpen market sale | -11307 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Gugino Matthew E Filed | Gugino Matthew E | Grant / award | +153.6K | |
Milosevich Gregory M Filed | Milosevich Gregory M | Grant / award | +15.4K | |
Sawyer Montgomery Julie A Filed | Sawyer Montgomery Julie A | Grant / award | +245.7K |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
75B+ROIC >12% Years0/10 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)57.4%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor13.3%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$5.70
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$6.19
Cash & short-term investments per share (Finnhub)
Book Value / Share$74.81
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$27.86B
Total debt obligations (short + long term)
Cash & Equiv.$4.35B
Cash and short-term investments
Net Debt$23.51B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$52.59B
Shareholders' equity (book value)
Asset / Liability2.32xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$161.01B
Current Market Capitalization
Beta0.79B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Danaher Corporation (DHR)
DHR is down 1.06% at the last close. Piotroski F-Score of 5/9 indicates mixed fundamentals for Danaher Corporation. Altman Z-Score of 3.47 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of -2.37 suggests a low likelihood of earnings manipulation.
- Revenue has been contracting (CAGR ≈ -4%), which weighs on the growth outlook.
- Danaher Corporation converts about 22% of revenue into free cash flow — strong cash generation.
- Takes ~4.3 years to repay net debt from free cash flow.
See how DHR ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all DHR moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 1 | Regular | 212.37 | -4.14% | -3.14 |
| Sep 30 | Regular | 221.01 | -2.26% | -2.04 |
Frequently Asked Questions about DHR
What is the current Danaher Corporation (DHR) stock price?
DHR is trading at $229.04 at the last market close, down 1.06% on the session. PreMarketPrice tracks DHR pre-market, intraday and after-hours prices.
Is DHR stock a buy right now?
PreMarketPrice's quantitative model rates Danaher Corporation's financial health at 80/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is DHR stock overvalued?
Danaher Corporation trades at a trailing P/E of 40.2 and our valuation score rates it 34/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Danaher Corporation report earnings?
No confirmed earnings date is currently scheduled for DHR. The Earnings section lists recent reports and updates as dates are announced.
What sector does Danaher Corporation operate in?
Danaher Corporation operates in the Healthcare sector, within the Diagnostics & Research industry. The Related Stocks section lists sector peers for comparison.
What does Danaher Corporation do?
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company.
About Danaher Corporation (DHR) Stock
Danaher Corporation (DHR) is a US-listed stock operating in the Healthcare sector, specifically the Diagnostics & Research industry. As of the latest update, Danaher Corporation is trading at $229.04, down 1.06% on the day with a market capitalization of $161.0 billion. The financial health score for DHR is 80/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for DHR stock.
DHR Stock Analysis & Key Metrics
On PreMarketPrice, you can track Danaher Corporation (DHR) across multiple dimensions:
- Pre-market price & movement: Real-time DHR stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for DHR with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Danaher Corporation across multiple reporting periods.
- Financial health score: A composite score of 80/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for DHR.
- Sector peers: Compare DHR against 6 other healthcare stocks on key financial metrics.
Is DHR a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Danaher Corporation (DHR) as an investment. The financial health score of 80/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Danaher Corporation (DHR) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.